These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16472740)

  • 41. Binding and catalysis: a thermodynamic study on a catalytic antibody system.
    Wade H; Scanlan TS
    Chembiochem; 2003 Jun; 4(6):537-40. PubMed ID: 12794866
    [No Abstract]   [Full Text] [Related]  

  • 42. Antibody catalysis of pericyclic reactions.
    Ulrich HD; Driggers EM; Schultz PG
    Acta Chem Scand (Cph); 1996 Apr; 50(4):328-32. PubMed ID: 8639375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transition-state stabilization as a measure of the efficiency of antibody catalysis.
    Stewart JD; Benkovic SJ
    Nature; 1995 Jun; 375(6530):388-91. PubMed ID: 7760931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A structural basis for the activity of retro-Diels-Alder catalytic antibodies: evidence for a catalytic aromatic residue.
    Hugot M; Bensel N; Vogel M; Reymond MT; Stadler B; Reymond JL; Baumann U
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9674-8. PubMed ID: 12093912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and characterization of single chain anti-cocaine catalytic antibodies.
    McKenzie KM; Mee JM; Rogers CJ; Hixon MS; Kaufmann GF; Janda KD
    J Mol Biol; 2007 Jan; 365(3):722-31. PubMed ID: 17084858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structures of Paenibacillus polymyxa beta-glucosidase B complexes reveal the molecular basis of substrate specificity and give new insights into the catalytic machinery of family I glycosidases.
    Isorna P; Polaina J; Latorre-García L; Cañada FJ; González B; Sanz-Aparicio J
    J Mol Biol; 2007 Aug; 371(5):1204-18. PubMed ID: 17585934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-resolution crystal structure of the Fab-fragments of a family of mouse catalytic antibodies with esterase activity.
    Ruzheinikov SN; Muranova TA; Sedelnikova SE; Partridge LJ; Blackburn GM; Murray IA; Kakinuma H; Takahashi-Ando N; Shimazaki K; Sun J; Nishi Y; Rice DW
    J Mol Biol; 2003 Sep; 332(2):423-35. PubMed ID: 12948492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural origins of efficient proton abstraction from carbon by a catalytic antibody.
    Debler EW; Ito S; Seebeck FP; Heine A; Hilvert D; Wilson IA
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):4984-9. PubMed ID: 15788533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution.
    Heine A; Stura EA; Yli-Kauhaluoma JT; Gao C; Deng Q; Beno BR; Houk KN; Janda KD; Wilson IA
    Science; 1998 Mar; 279(5358):1934-40. PubMed ID: 9506943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissecting the catalytic mechanism of a plant beta-D-glucan glucohydrolase through structural biology using inhibitors and substrate analogues.
    Hrmova M; Fincher GB
    Carbohydr Res; 2007 Sep; 342(12-13):1613-23. PubMed ID: 17548065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment.
    Kuhar MJ; Carroll FI; Bharat N; Landry DW
    Synapse; 2001 Aug; 41(2):176-8. PubMed ID: 11400184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Theoretical study of catalytic efficiency of a Diels-Alderase catalytic antibody: an indirect effect produced during the maturation process.
    Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
    Chemistry; 2008; 14(2):596-602. PubMed ID: 17960540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereoselectivity behavior of the AZ28 antibody catalyzed oxy-Cope rearrangement.
    Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J
    J Phys Chem A; 2006 Jan; 110(2):726-30. PubMed ID: 16405346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nylon-oligomer degrading enzyme/substrate complex: catalytic mechanism of 6-aminohexanoate-dimer hydrolase.
    Negoro S; Ohki T; Shibata N; Sasa K; Hayashi H; Nakano H; Yasuhira K; Kato D; Takeo M; Higuchi Y
    J Mol Biol; 2007 Jun; 370(1):142-56. PubMed ID: 17512009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of enzyme motions by solution NMR relaxation dispersion.
    Loria JP; Berlow RB; Watt ED
    Acc Chem Res; 2008 Feb; 41(2):214-21. PubMed ID: 18281945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformational changes in a plant ketol-acid reductoisomerase upon Mg(2+) and NADPH binding as revealed by two crystal structures.
    Leung EW; Guddat LW
    J Mol Biol; 2009 May; 389(1):167-82. PubMed ID: 19362563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Origins and predictions of stereoselective antibody catalysis: theoretical analysis of Diels-Alder catalysis by 39A11 and its germ-line antibody.
    Zhang X; Deng Q; Yoo SH; Houk KN
    J Org Chem; 2002 Dec; 67(25):9043-53. PubMed ID: 12467427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, properties, and reactivity of cocaine benzoylthio ester possessing the cocaine absolute configuration.
    Isomura S; Hoffman TZ; Wirsching P; Janda KD
    J Am Chem Soc; 2002 Apr; 124(14):3661-8. PubMed ID: 11929256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.